MicroRNA-27a decreases the level and efficiency of the LDL receptor and contributes to the dysregulation of cholesterol homeostasis

Atherosclerosis
M Lucrecia AlvarezStefania C Done

Abstract

A strong risk factor for atherosclerosis- the leading cause of heart attacks and strokes- is the elevation of low-density lipoprotein cholesterol (LDL-C) in blood. The LDL receptor (LDLR) is the primary pathway for LDL-C removal from circulation, and their levels are increased by statins -the main treatment for high blood LDL-C. However, statins have low efficiency because they also increase PCSK9 which targets LDLR for degradation. Since microRNAs have recently emerged as key regulators of cholesterol homeostasis, our aim was to identify potential microRNA-based therapeutics to decrease blood LDL-C and prevent atherosclerosis. We over expressed and knocked down miR-27a in HepG2 cells to assess its effect on the expression of key players in the LDLR pathway using PCR Arrays, Elisas, and Western blots. We found that miR-27a decreases LDLR levels by 40% not only through a direct binding to its 3' untranslated region but also indirectly by inducing a 3-fold increase in PCSK9, which enhances LDLR degradation. Interestingly, miR-27a also directly decreases LRP6 and LDLRAP1, two other key players in the LDLR pathway that are required for efficient endocytosis of the LDLR-LDL-C complex in the liver. The inhibition of miR-27a using loc...Continue Reading

References

Sep 11, 2002·The Journal of Biological Chemistry·Guocheng HeJonathan C Cohen
May 6, 2003·Nature Genetics·Marianne AbifadelCatherine Boileau
Oct 23, 2003·European Journal of Human Genetics : EJHG·Marian BeekmanP Eline Slagboom
Sep 17, 2004·Nature·Victor Ambros
Oct 27, 2004·PLoS Biology·Bino JohnDebora S Marks
Jun 28, 2005·FEBS Letters·Hanjiang FuXiaofei Zheng
Feb 7, 2006·Cell Metabolism·Christine EsauBrett P Monia
Nov 3, 2006·Nature Reviews. Drug Discovery·Jane Kidd
Jul 7, 2007·Molecular Cell·Andrew GrimsonDavid P Bartel
Jan 30, 2008·Proceedings of the National Academy of Sciences of the United States of America·Robert F PlaceRajvir Dahiya
Apr 11, 2009·World Journal of Gastroenterology : WJG·Xian-Ming Chen
Aug 5, 2009·Expert Opinion on Therapeutic Targets·Huangming XieHarvey F Lodish
Nov 17, 2009·QJM : Monthly Journal of the Association of Physicians·J K DowmanP N Newsome
Feb 4, 2010·Journal of Lipid Research·Dimitrios IliopoulosVassilis I Zannis
May 15, 2010·Science·S Hani Najafi-ShoushtariAnders M Näär
May 15, 2010·Science·Katey J RaynerCarlos Fernández-Hernando
Sep 4, 2010·Circulation Research·Riccardo ContuGianluigi Condorelli
Mar 29, 2011·Bioinformatics·Daniel C EllwangerVolker Stümpflen
Sep 13, 2011·Nature Structural & Molecular Biology·David M GarciaDavid P Bartel
Nov 5, 2011·Nucleic Acids Research·Vera HuangLong-Cheng Li
Nov 24, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Marie W LindholmTroels Koch
Dec 1, 2011·The Journal of Biological Chemistry·Zhi-jia YeArya Mani
Feb 7, 2012·Atherosclerosis·Wu-Jun ChenChao-Ke Tang
Jul 11, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Kasey C VickersPraveen Sethupathy
Oct 4, 2012·The Journal of Clinical Endocrinology and Metabolism·Dwi Setyowati KarolinaKandiah Jeyaseelan
Jul 6, 2014·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·Z Reiner
Nov 21, 2014·Journal of Atherosclerosis and Thrombosis·Sha Li, Jian-Jun Li
Dec 3, 2014·Journal of Diabetes and Its Complications·Vasilios G AthyrosDimitri P Mikhailidis
Dec 19, 2014·Circulation·Dariush MozaffarianUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee

❮ Previous
Next ❯

Citations

Feb 13, 2016·Biochimica Et Biophysica Acta·Ángel Baldán, Thomas Q de Aguiar Vallim
Feb 2, 2016·Atherosclerosis·Noemi RotllanCarlos Fernández-Hernando
Mar 13, 2016·Biochimica Et Biophysica Acta·Leigh GoedekeAnders M Näär
Apr 22, 2016·European Heart Journal·Peter WilleitManuel Mayr
May 26, 2016·International Journal of Molecular Sciences·Pablo LetelierJuan Carlos Roa
Apr 4, 2017·Expert Opinion on Investigational Drugs·Gerald H Tomkin, Daphne Owens
Mar 27, 2018·Annals of Medicine·Najmeh AhangariAlireza Pasdar
Feb 13, 2019·Asian-Australasian Journal of Animal Sciences·Yueyun DingZongjun Yin
Jun 13, 2020·Frontiers in Cardiovascular Medicine·Alessandro G SalernoKathryn J Moore
Sep 11, 2020·Cardiovascular Diabetology·Karima Ait-AissaModar Kassan
Dec 13, 2017·Frontiers in Genetics·Parisa NaeliSeyed J Mowla
Jul 8, 2020·International Journal of Molecular Sciences·Unai Galicia-GarciaCésar Martín
May 24, 2017·Clinical Reviews in Allergy & Immunology·Amir Abbas MomtaziAmirhossein Sahebkar
Jun 19, 2019·Oxidative Medicine and Cellular Longevity·Vladan P BajicEsma R Isenovic
Aug 28, 2019·American Journal of Physiology. Endocrinology and Metabolism·Jerad H DumoltTodd C Rideout
Dec 19, 2019·Journal of Clinical Medicine·Emma L SollyJoanne T M Tan
Feb 20, 2020·Molecular and Cellular Biology·Abrar A KhanNitish R Mahapatra
Nov 19, 2015·Molecular Nutrition & Food Research·Johann GuillemotNabil G Seidah
Jul 28, 2020·Journal of Atherosclerosis and Thrombosis·Ece YurtsevenLale Tokgözoğlu
Nov 6, 2018·International Journal of Molecular Sciences·Asier Benito-VicenteCesar Martin
May 22, 2018·Current Atherosclerosis Reports·Paola Toledo-Ibelles, Jaime Mas-Oliva
Nov 5, 2019·The Canadian Journal of Cardiology·Pauline Labbé, Eric Thorin
Feb 2, 2021·Annals of the New York Academy of Sciences·Kathryn M CitrinYajaira Suárez
Dec 12, 2021·Acta Pharmacologica Sinica·Lin RuJun-Qi Niu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anxiety Disorders

Discover the latest research on anxiety disorders including agoraphobia, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder here.

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Carotid Artery Diseases

Carotid artery disease is a group of pathological conditions of the carotid artery. Discover the latest research on carotid artery disease here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Related Papers

Journal of Atherosclerosis and Thrombosis
Sha Li, Jian-Jun Li
Expert Opinion on Therapeutic Targets
Christopher J Duff, Nigel M Hooper
Current Pharmaceutical Design
Maciej BanachEsma R Isenovic
Nature Clinical Practice. Cardiovascular Medicine
Anne K Soutar, Rossi P Naoumova
© 2021 Meta ULC. All rights reserved